SOMAREALITY

Name: SOMAREALITY
Brand: SOMAREALITY

AI Native

Real-time cognitive monitoring based on eye tracking

Est 2020|11 Ref Customers

LinkedIn 3K|Web traffic 2K|FTEs 14|HQ Vienna, Vienna, AT

Published Aug 18, 2026

01Common complaints

- If mature enterprise compliance artifacts are required upfront - SOMAREALITY does not publicly document SOC 2/ISO certifications, data residency, or enterprise IAM features in the accessed sources. - If widely benchmarked, standardized metrics are the only requirement - If the primary need is gaze mapping, AOIs, heatmaps, and standard fixation/saccade metrics, platforms like Tobii Pro Lab or Pupil Cloud may be simpler and have broader validation in mainstream research workflows. - If the organization cannot invest in validation and calibration of cognitive-state metrics - Cognitive load and perception indices often require context-specific interpretation. If plug-and-play operational decisions with minimal validation are required, the risk profile may be high. - If price transparency and self-serve trials are essential - SOMAREALITY uses quote-based pricing (per biomarker yearly license or lifetime access), which may be incompatible with teams that require instant purchase and predictable tiers. - If the workflow requires a widely documented ecosystem with many trained operators - Tobii and Pupil Labs have broader visibility, more widespread documentation/tooling, and clearer pricing for key components, which can reduce training risk. - Lack of public third-party reviews and benchmark comparisons - No accessible G2/TrustRadius/Capterra listings and no visible Gartner Peer Insights product page were found; this limits external validation. - Website operational maturity signals - Some official pages showed reCaptcha configuration errors in the crawled view, which may indicate occasional web operations issues. - Roadmap / not-yet-available features - A distributor/news post referenced a planned "Cognitive Fatigue" feature targeted for completion in 2026 Q3 (July–September 2026). As of the date of this report, buyers should confirm current availability and release status directly with SOMAREALITY. - Scientific/measurement limitations (category-level) - Pupillometry and eye movement metrics can be influenced by: - Lighting and display luminance (the vendor highlights compensation for this) - Emotional arousal and stress - Pharmacological factors (caffeine, medications) - Individual differences - Outputs should be treated as probabilistic indicators and validated against task performance and other sensors when possible (EEG/HRV/etc.).

Deal disqualifiers: what makes a poor fit

Organizations that require strong third-party review validation and a mature marketplace footprint before procurement.
Organizations that require publicly documented SOC 2/ISO certifications before security approval.
Organizations that need only commodity eye-tracking metrics (heatmaps/AOIs) and not cognitive-state inference.

02Why they buy

- Cognitive biomarkers beyond traditional gaze-location analytics - The vendor positions the product as providing higher-level cognitive constructs (load, conscious perception/engagement, attention types, fatigue) derived from eye-tracking signals. - Brightness compensation (vendor claim; requires verification) - SOMAREALITY states it applies an approach to compensate for environmental brightness changes in pupillometry-based load estimation. Procurement teams should request validation and comparative benchmarks. - Stated hardware compatibility - SOMAREALITY states compatibility with a range of eye-tracking solutions and references integrations with vendors such as Tobii and Pupil Labs. Practical compatibility depends on access to required data streams (pupil diameter, confidence, scene video, etc.) and signal quality.

03Field reports

- Summary of availability of third-party reviews - Gartner Peer Insights - No SOMAREALITY product listing or reviews were found via accessible public search results; Gartner’s Peer Insights platform generally requires login to view detailed reviews, and some vendor/product pages may not be indexed publicly. - G2 - No SOMAREALITY product page with reviews was found in accessible search results. - TrustRadius - No SOMAREALITY product page with reviews was found in accessible search results. - Capterra - No SOMAREALITY product listing with reviews was found via accessible search results. - Implication: the standard review-platform footprint appears minimal to nonexistent (at least publicly visible). This forces heavier reliance on official materials, partner write-ups, and scattered community mentions. - Community / social discussion (Reddit) — limited but relevant - A Reddit post in r/cognitivescience ("Continuous Cognitive Monitoring") mentions SOMAREALITY as the only company the poster could find for continuous cognitive monitoring using eye tracking for cognitive load/attention/orientation/perception. - This is not an end-user product review, but it indicates discoverability within niche cognitive science communities. - Partner/customer-story style sources (not independent reviews) - Tobii published a customer story describing SOMAREALITY building cognitive load measurement in VR, referencing use of Pico Neo 3 Pro Eye (with Tobii eye tracking) and quotes attributed to SOMAREALITY’s Director of Strategic Partnerships. - This supports that SOMAREALITY has an industry partnership footprint, but the content is presented in a partner-authored context. - Vendor-provided testimonial example (official site) - SOMAREALITY’s homepage includes a vendor-provided testimonial attributed to “Dr. Walter • Austrian Armed Forces” describing cognitive readiness for paramedics and reporting a positive operational impact. No supporting methodology, deployment scope, or quantified outcomes were provided alongside the quote. - Balanced take despite limited reviews - Positive signals (weakly validated) - The vendor articulates a non-invasive alternative to EEG/fNIRS for certain operational contexts. - Messaging emphasizes hardware compatibility and real-world applicability. - Evidence of partnerships and mentions by eye-tracking ecosystem companies (Tobii; Pupil Labs is recommended as compatible hardware by SOMAREALITY) appears in partner materials. - Negative/uncertain signals - Scarcity of independent user reviews on mainstream B2B review platforms makes it difficult to validate claims about usability, reliability, and ROI. - Cognitive state inference is sensitive to confounds; the absence of broad, third-party validation datasets in public materials increases buyer validation burden.

Official website “Explore the case” items

The vendor site references case studies across healthcare, aviation, automotive, and research; the accessible content for this research session did not include full detailed case study pages with quantitative results.
Critical note: in the absence of detailed metrics and methodology, it is difficult to evaluate actual impact.

Partner case study: Tobii x SOMAREALITY (VR cognitive load)

Tobii’s customer story describes SOMAREALITY’s approach to measuring cognitive load in VR and highlights integration with Pico Neo 3 Pro Eye and Tobii Ocumen signals.
Critical evaluation
- As a partner-authored story, the content is likely to emphasize positive outcomes and omit challenges.
- It is useful for understanding technical stack and positioning, but not for independent ROI validation.

Vendor whitepaper: “Eye Tracking meets EEG” (validation framing)

- SOMAREALITY published a whitepaper describing two proprietary biomarkers (Cognitive Load and Conscious Perception) and discusses validation framing versus EEG paradigms. - Critical evaluation - This is vendor-authored and can be informative for conceptual approach and references, but should not be treated as independent validation. - Procurement teams should request: - Dataset description - Sample size and demographics - Hardware used - Ground truth labels and statistical tests - Out-of-sample/generalization results

Grant program as an ecosystem-building strategy

SOMAREALITY runs an R&D Grant Program offering a cash grant and free access to algorithms, with a stated deadline in 2026 (now in the past relative to this report).
Critical evaluation
- The program can accelerate academic and industry experimentation and evidence generation.
- It can also indicate the vendor is actively expanding evidence and building a user base.

04Best fit

Company sizes (estimated)

Mid-market to enterprise organizations where safety, training efficacy, or cognitive performance has measurable business impact.
Applied research labs (university, hospital, defense) with budgets for eye-tracking hardware and staff for study design.

Industries and verticals where adoption is most likely (based on vendor positioning)

Healthcare (surgical training/monitoring; cognitive readiness)
Aviation (pilot training)
Automotive (driver/passenger monitoring)
Academic and industrial research in neuroergonomics / human factors

Roles and personas

Decision makers
- Head of Training / Simulation
- Chief Medical Officer / Director of Clinical Training
- Human Factors / Safety leadership
- R&D / Innovation leads
End users
- Researchers (cognitive science, HCI, neuroscience)
- Simulation engineers
- Data scientists / ML engineers
- UX research teams (if cognitive load metrics are used for interface evaluation)

Pain points and challenges the product addresses

Need for objective, continuous signals of mental workload/engagement without complex EEG setups.
Need to evaluate training scenarios and identify overload/fatigue risk.
Need to deploy measurement outside lab conditions where EEG is impractical.

Qualification criteria: what makes a good fit

Organizations that already have (or plan to procure) reliable eye-tracking hardware.
Organizations prepared to run pilot studies and validate outputs against their operational ground truth.
Organizations with use cases where cognitive load or perception metrics can drive measurable interventions (training redesign, safety rules, adaptive UX).

05The pitch

What the product does (core value proposition in objective terms)

- SOMAREALITY (often shortened to “SOMA”) provides software algorithms that transform eye-tracking signals (e.g., pupil dilation, fixations, saccades, gaze stability) into digital biomarkers intended to estimate cognitive states such as cognitive load, conscious perception/engagement, attention modes, and (roadmap / emerging) cognitive fatigue. - The product is presented as a non-invasive, real-time method for monitoring cognition outside controlled labs, with stated emphasis on compensating for environmental confounds such as brightness changes. - SOMA provides a workflow that includes calibrate/record, then upload/analyze via a dashboard ("SOMA Aware") and/or integration via SDK/API for embedding into customer systems.

Target market and market positioning

Targeted primarily at B2B and applied research use cases requiring cognitive state inference from wearable or remote eye tracking.
Vertical messaging focuses on healthcare (training/monitoring), aviation (pilot training), automotive (driver/passenger state), and research/neuroergonomics.
Market position appears to be a cognitive analytics layer on top of third-party eye trackers, rather than an eye-tracking hardware vendor.

Get a comprehensive analysis of SOMAREALITY including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →